Log in to search using one of your social media accounts:

 

BenevolentAI Makes Joanna Shields New CEO
London drug discovery startup BenevolentAI has made former Silicon Valley executive Joanna Shields its group CEO. Shields previously held managing director roles at Google and Facebook, before moving into UK politics. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 2, 2018 Category: Pharmaceuticals Authors: Sam Shead, Contributor Source Type: news

South Africa: How Cape Town beat the drought
The city was on the verge of becoming the first major urban centre to run out of water but has averted the crisis. But for how long, and at what cost, in a divided country? (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 2, 2018 Category: Pharmaceuticals Source Type: news

Backed by big-name VCs, this startup is turning machine learning on drug discovery
Daphne Koller, the former ed-tech entrepreneur who jumped to anti-aging drug research company Calico, is launching a company turning machine learning on drug discovery and development with the backing of prominent biotech venture capital firms at the intersection of tech and biotech. Not much is known at this point about Insitro, backed by Foresite Capital, Alphabet investment arm GV, Third Rock Ventures, Andreessen Horowitz and ARCH Ventures. But the company's website says it will apply machine… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 2, 2018 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Mayo Clinic No. 10 on DiversityInc's Top Hospitals and Health Systems ranking
ROCHESTER, Minn. ? Mayo Clinic again was named to DiversityInc's Top Hospitals and Health Systems ranking. This is the seventh consecutive year that Mayo has been ranked among the top health care organizations for its commitment to diversity, inclusion and equity. Sharonne Hayes, M.D., medical director of Mayo Clinic's Office of Diversity and Inclusion, says [...] (Source: Mayo Clinic Business News)
Source: Mayo Clinic Business News - May 2, 2018 Category: Pharmaceuticals Source Type: news

Partnership gives Ontarians wide-spread access to spencer for...
High-risk patients across Ontario can now rely on spencer, an in-home medication dispenser and connected device, to help them maintain their independence at home(PRWeb May 02, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15457917.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 2, 2018 Category: Pharmaceuticals Source Type: news

Biogen to Receive the Lifetime Achievement Award at Boston CEO, Taking...
This year's award ceremony will convene industry thought leaders to recognize the accomplishments of a local biotech success story.(PRWeb May 02, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15460183.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 2, 2018 Category: Pharmaceuticals Source Type: news

ISPE CEO and President Recognized as a Top Pharmaceutical Industry...
ISPE CEO and President John Bournas was recognized as a top-10 Industry Influencer on The Medicine Maker’s 2018 Power List.(PRWeb May 02, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15458135.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 2, 2018 Category: Pharmaceuticals Source Type: news

ACRES Augments Board of Directors in Building for the Future of Health...
The Alliance for Clinical Research Excellence and Safety (ACRES), a Global Life Sciences Collaborative, Throttles-up Leadership as Implementation of a Comprehensive Integrated System for Health Care...(PRWeb May 02, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15457485.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 2, 2018 Category: Pharmaceuticals Source Type: news

PharmaPoint Announces Grand Opening of New Outpatient Pharmacy at “The...
PharmaPoint is proud to announce today’s grand opening of El Camino Hospital Outpatient Pharmacy.(PRWeb May 02, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15456989.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 2, 2018 Category: Pharmaceuticals Source Type: news

Gilead shares rattled by sharp slide in hepatitis C drug sales
(Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 1, 2018 Category: Pharmaceuticals Source Type: news

Knowledge of Causes of Cancer Low in General Population
TUESDAY, May 1, 2018 -- Among the general population, awareness of actual and mythical causes of cancer is poor, according to a study published online April 25 in the European Journal of Cancer. Lion Shahab, Ph.D., from University College London,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 1, 2018 Category: Pharmaceuticals Source Type: news

Doctors Generally Confident With Deprescribing for Elderly
TUESDAY, May 1, 2018 -- Physicians are generally comfortable with deprescribing for elderly patients, although there are several barriers to deprescribing, according to a study published online April 22 in the Journal of Clinical Pharmacy and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 1, 2018 Category: Pharmaceuticals Source Type: news

Glyburide Not Noninferior to Insulin for Gestational Diabetes
TUESDAY, May 1, 2018 -- For women with gestational diabetes, glyburide is not noninferior to insulin, according to a study published in the May 1 issue of the Journal of the American Medical Association. Marie-Victoire S énat, M.D., Ph.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 1, 2018 Category: Pharmaceuticals Source Type: news

Synthetic Opioid Involvement in Opioid-Related Deaths Up
TUESDAY, May 1, 2018 -- Synthetic opioid involvement in opioid-related overdose deaths increased significantly from 2010 to 2016, according to a research letter published in the May 1 issue of the Journal of the American Medical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 1, 2018 Category: Pharmaceuticals Source Type: news

Practices Should Be Aware of Correct Way to Fire Employees
TUESDAY, May 1, 2018 -- Physicians should be aware of the correct protocol for, as well as the laws involved in, firing employees, according to a report published in Medical Economics. The article suggests compiling an employee handbook, which... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 1, 2018 Category: Pharmaceuticals Source Type: news

Pfizer says it is not looking for a mega-deal
CEO Ian Read wants to spend capital on developing experimental medicines (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 1, 2018 Category: Pharmaceuticals Source Type: news

With Viagra Now Available Over-The-Counter In The U.K., Will The U.S. Follow Suit?
Given these factors, it wouldn ’t be a surprise to see FDA head, Dr. Scott Gottlieb, move the agency toward making OTC Viagra available in the US. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 1, 2018 Category: Pharmaceuticals Authors: John LaMattina, Contributor Tags: NYSE:PFE Source Type: news

Beckman Coulter Launches the DxH 900 Hematology Analyzer
System helps laboratories deliver fast, accurate results through near native-state cellular characterization, precise flagging and a 93% first-pass throughput[1] BREA, Calif., May 1, 2018 -- (Healthcare Sales & Marketing Network) -- Beckman Coulter ann... Devices, Diagnostics, Product Launch Beckman Coulter, DxH 900, hematology analyzer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 1, 2018 Category: Pharmaceuticals Source Type: news

Agendia's MammaPrint(R) Receives Positive Coverage Decisions from Three Major Private Healthcare Insurers
Decisions from Aetna, Cigna and UnitedHealthcare followed the latest update to the American Society of Clinical Oncology (ASCO) guidelines recommending MammaPrint® Breast Cancer Risk of Recurrence Test for certain breast cancer patients Majority of ... Diagnostics, Personalized Medicine, Oncology, Reimbursement Agendia, MammaPrint (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 1, 2018 Category: Pharmaceuticals Source Type: news

SCYNEXIS's Oral SCY-078 Receives FDA QIDP and Fast Track Designations for the Treatment of VVC and Prevention of Recurrent VVC
QIDP provides five additional years of market exclusivity, and Fast Track expedites the regulatory path Enrollment completed in Phase 2b DOVE study in VVC; on-track for top-line data by July 2018 Initiation of Phase 3 registration program in VVC plan... Biopharmaceuticals, FDA SCYNEXIS, SCY-078, antifungal, candidiasis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 1, 2018 Category: Pharmaceuticals Source Type: news

Why A Giant Health Insurer Is Diagnosing America With Loneliness
This morning, Cigna, the $42 billion (sales) insurance giant, released a survey of 20,000 people conducted with polling firm Ipsos with which it ’s diagnosing America with a new ailment: loneliness. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 1, 2018 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Tags: NYSE:CI Source Type: news

Pharma's Opioid CME; $3M Research Breach; Novo's Insulin Pushback
(MedPage Today) -- the past week of investigations into healthcare (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - May 1, 2018 Category: Urology & Nephrology Source Type: news

Why Lethal Autonomic Weapons Offer The World A Dark Future
Drones can offer society a lot but they also have an increasingly dark potential that is being realised. What is the future of drone technology? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 1, 2018 Category: Pharmaceuticals Authors: Paul Armstrong, Contributor Source Type: news

Wellsmith And Cone Health Launch New Digital Care Platform
Wellsmith Inc, an up-and-coming provider of digital health and wellness solutions, announced the launch of a new digital care platform for the treatment of chronic lifestyle diseases. Today I wanted to talk a bit about the solution and offer my take on it. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 1, 2018 Category: Pharmaceuticals Authors: Patrick Moorhead, Contributor Tags: NASDAQ:TISI Source Type: news

Bill Gates Calls For, And Funds, Steps To Prevent A Global Pandemic
For years Bill Gates has been an optimist about the future of global public health. However, there is one area that worries him — the possibility of a global pandemic. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 1, 2018 Category: Pharmaceuticals Authors: Michela Tindera, Forbes Staff Source Type: news

Riding The Disruption Wave In Healthcare
Change is coming to healthcare. Investors that figure out how to prepare for, navigate and profit from disruption stand to benefit. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 1, 2018 Category: Pharmaceuticals Authors: Bain Insights, Contributor Source Type: news

Regeneron, Sanofi strike pricing deal with Express Scripts for cholesterol drug
Regeneron Pharmaceuticals (NSDQ:REGN) and its partner, Sanofi (NYSE:SNY), have agreed to lower the cost for its cholesterol drug, Praluent, for Express Scripts (NSDQ:ESRX) in exchange for an exclusive spot on the pharmacy benefit manager’s national formulary. The agreement, effective July 1, is designed to broaden patient access to the injectable medicine and lower out-of-pocket costs for eligible patients, according to the pharma companies. Get the full story at our sister site, Drug Delivery Business News. The post Regeneron, Sanofi strike pricing deal with Express Scripts for cholesterol drug appeared fi...
Source: Mass Device - May 1, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Cardiovascular Pharmaceuticals Wall Street Beat Express Scripts Regeneron Sanofi-Aventis Source Type: news

Drinking frequency increases with income
About 70% of people in managerial and professional jobs have drunk alcohol in past week (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 1, 2018 Category: Pharmaceuticals Source Type: news

Cigna Finds More Evidence Of Loneliness In America
This is what a recent survey conducted by Cigna and Ipsos of over 20,000 Americans ages 18 years and older revealed. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 1, 2018 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Here Is More Evidence That Americans Are Lonely And What Should Be Done
This is what a recent survey conducted by Cigna and Ipsos of over 20,000 Americans ages 18 years and older revealed. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 1, 2018 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

EverlyWell, which can tell if you have STDs or gluten sensitivity, names first CFO as it aims for $20M in annual revenue
Sales have taken off at EverlyWell since it appeared on "Shark Tank" — so much so that it needs a new executive in the C-suite in charge of its ballooning finances. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 1, 2018 Category: Pharmaceuticals Authors: Will Anderson Source Type: news

Henry Schein President James Breslawski Assumes New Role As Vice Chairman
Jonathan Koch Joins to Lead Global Dental Distribution Group MELVILLE, N.Y., May 1, 2018 -- (Healthcare Sales & Marketing Network) -- Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based d... Devices, Personnel Henry Schein (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 1, 2018 Category: Pharmaceuticals Source Type: news

Pharmaceutical Business Development Leader Dr. Kevin Lynch Joins Recursion as Chief Business Officer
SALT LAKE CITY, May 1, 2018 -- (Healthcare Sales & Marketing Network) -- Recursion Pharmaceuticals, a biotechnology company that combines artificial intelligence (AI), experimental biology, and automation to discover drugs at scale, today announced it has... Biopharmaceuticals, Personnel Recursion Pharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 1, 2018 Category: Pharmaceuticals Source Type: news

Aetna Adds 250K Medicare Advantage Enrollees Ahead Of CVS Deal
Aetna, which is working its way through a sale to CVS Health, said it added 250,000 new customers to its Medicare Advantage plans in the first quarter. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 1, 2018 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NYSE:CVS NYSE:ANTM NYSE:AET NYSE:CI NYSE:UNH Source Type: news

ProMIS Neurosciences Closes $7.2 Million Private Placement
TORONTO and CAMBRIDGE, MA, May 1, 2018 -- (Healthcare Sales & Marketing Network) - ProMIS Neurosciences Inc. (TSX:PMN; OTCQB:ARFXF) is pleased to announce that it closed yesterday a private placement of 19,306,668 Units at the price of CDN$0.375 per Unit ... Biopharmaceuticals, Neurology, Venture Capital ProMIS Neurosciences, Alzheimer's disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 1, 2018 Category: Pharmaceuticals Source Type: news

Regeneron and Sanofi to Lower Net Price of Praluent(R) (alirocumab) Injection in Exchange for Straightforward, More Affordable Patient Access for Express Scripts Patients
Agreement provides Praluent at lower net price and enables streamlined patient access based on physician attestation Express Scripts to pass on savings to eligible patients from the participating commercial health plans Express Scripts has selected P... Biopharmaceuticals, Reimbursement Regeneron Pharmaceuticals, Sanofi, Praluent, alirocumab, PCSK9 inhibitor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 1, 2018 Category: Pharmaceuticals Source Type: news

Cambridge ’s Ironwood Pharmaceuticals to split into two businesses
Cambridge-based Ironwood Pharmaceuticals said Tuesday that it plans to separate into two publicly-traded companies, one focused on the company ’s commercial business of gastrointestinal drugs, and the other focused on developing treatments for rare disorders and other serious conditions. Ironwood (Nasdaq: IRWD) said that both businesses would be headquartered in Cambridge. A spokesperson did not immediately respond to a request for comm ent on how many of the company’s 730 employees globally would… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 1, 2018 Category: Pharmaceuticals Authors: Max Stendahl Source Type: news

As Specialty Drugs Gain Share, Trump Looks To Curb Prices
The share specialty drugs have of total U.S. pharmaceutical sales nears 50% as President Trump prepares to unveil proposals to curtail drug prices. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 1, 2018 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NASDAQ:WBA NASDAQ:ESRX NYSE:CVS NYSE:RAD NYSE:EXPR Source Type: news

Merck lifts earnings forecast after currency boost
(Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 1, 2018 Category: Pharmaceuticals Source Type: news

United Therapeutics acquiring rival drugmaker
United Therapeutics Corp. has reached a deal to acquire Israel-based SteadyMed Therapeutics Inc. in a deal that's potentially valued at $216 million and that eliminates a serious competitive threat to the Maryland biotech. The Silver Spring drugmaker will acquire SteadyMed for $4.46 per share in cash at closing, already a 68 percent premium on the smaller company's closing price Friday, totaling $141 million. In addition, United Therapeutics has offered another $2.63 per share in cash if SteadyMed's… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 1, 2018 Category: Pharmaceuticals Authors: Sara Gilgore Source Type: news

Biomarkers can predict diabetes diagnosis 20 years in advance
A new Swedish study finds that patients who pay attention to certain biological markers of overall health can predict their likelihood of getting type 2 diabetes 20 years in advance and make the lifestyle changes necessary to prevent it.   The study, published in the online journal Diabetes, Obesity and Metabolism, found that body mass index, fasting triglycerides and fasting glucose numbers are reliable indicators of whether people would develop the disease. “The results of the present study… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 1, 2018 Category: Pharmaceuticals Authors: Anne Stych Source Type: news

Clinical Upstaging of NSCLC Seen With Each Progressive Week
TUESDAY, May 1, 2018 -- For patients with non-small-cell lung cancer (NSCLC), significant upstaging can occur in each successive week from initial staging to surgery, according to a study presented at the annual meeting of the American Association... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 1, 2018 Category: Pharmaceuticals Source Type: news

Severe Obesity Tied to Faster Progression to Disability With RA
TUESDAY, May 1, 2018 -- Severe obesity is associated with more rapid progression of disability in patients with rheumatoid arthritis (RA), according to a study published online April 30 in Arthritis Care& Research. Joshua F. Baker, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 1, 2018 Category: Pharmaceuticals Source Type: news

Anesthesia Before Age 3 Not Linked to Intelligence Deficits
TUESDAY, May 1, 2018 -- Multiple exposures to anesthesia before the age of 3 years may have neuropsychological impacts, though intelligence does not appear to be affected, according to a study published online April 18 in Anesthesiology. David O.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 1, 2018 Category: Pharmaceuticals Source Type: news

Maternal, Child Sugar Intake Could Impact Child Cognition
TUESDAY, May 1, 2018 -- Greater sugar consumption during pregnancy and early childhood may adversely impact child cognition, according to a study published online April 16 in the American Journal of Preventive Medicine. Juliana F.W. Cohen, Sc.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 1, 2018 Category: Pharmaceuticals Source Type: news

Early Readmissions More Preventable Than Later Ones
TUESDAY, May 1, 2018 -- Early general medicine readmissions are more likely than late readmissions to be preventable with hospital-based interventions, according to a study published online May 1 in the Annals of Internal of Medicine. Kelly L.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 1, 2018 Category: Pharmaceuticals Source Type: news

Perioperative MACCEs More Common With Diabetes
TUESDAY, May 1, 2018 -- Perioperative major adverse cardiovascular and cerebrovascular events (MACCEs) are more common among patients with diabetes mellitus (DM), according to a study published online April 4 in Diabetes Care. Jonathan D. Newman,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 1, 2018 Category: Pharmaceuticals Source Type: news

Timely Receipt of PCI in STEMI Up With Hospital Bypass Policy
TUESDAY, May 1, 2018 -- Adoption of policies allowing emergency medical services (EMS) to bypass non-percutaneous coronary intervention (PCI) capable hospitals for patients with ST-segment elevation myocardial infarction (STEMI) is associated with... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 1, 2018 Category: Pharmaceuticals Source Type: news

Leader of Seton parent Ascension considered for top VA post, report says
Ascension President and CEO Anthony Tersigni is on the short list to become the next secretary of Veterans Affairs. According to Modern Healthcare, Tersigni is among those being considered for the job, along with acting secretary Robert Wilkie, Cleveland Clinic CEO Dr. Toby Cosgrove, Rep. Phil Roe (R-Tennessee) and former congressman Jeff Miller (R-Florida). Tersigni has lead Ascension for the past 13 years an d helped the system become one of the biggest participants in the VA Choice program, the… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 1, 2018 Category: Pharmaceuticals Authors: Vince Brennan Source Type: news

Metabolically Healthy Obesity Not Without Risk of CVD
TUESDAY, May 1, 2018 -- Metabolically healthy obesity (MHO) is not a stable or reliable indicator of future cardiovascular disease (CVD) risk, according to a study published in the May 1 issue of the Journal of the American College of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 1, 2018 Category: Pharmaceuticals Source Type: news